Cargando…

Validation of the hepatocellular carcinoma early detection screening algorithm Doylestown and aMAP in a cohort of Chinese with cirrhosis

BACKGROUND: Previous studies have developed some blood‐based biomarker algorithms such as the Doylestown algorithm and aMAP score to improve the detection of Hepatocellular carcinoma (HCC). However, no one has studied the application of the Doylestown algorithm in the Chinese. Meanwhile, which of th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qian, Yunsong, Li, Linhong, Ma, Li, Ji, Rengbin, Ying, Sheng, Zhou, Juhong, Fu, Liyun, Yang, Gang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8993634/ https://www.ncbi.nlm.nih.gov/pubmed/35218083 http://dx.doi.org/10.1002/jcla.24296

Ejemplares similares

Application of the Doylestown algorithm for the early detection of hepatocellular carcinoma
por: Mehta, Anand S., et al.
Publicado: (2018)

Correction: Application of the Doylestown algorithm for the early detection of hepatocellular carcinoma
por: Mehta, Anand S., et al.
Publicado: (2018)

External Validation of aMAP Hepatocellular Carcinoma Risk Score in Patients With Chronic Hepatitis B-Related Cirrhosis Receiving ETV or TDF Therapy
por: Gui, Honglian, et al.
Publicado: (2021)

Evaluation of the aMAP score for hepatocellular carcinoma surveillance: a realistic opportunity to risk stratify
por: Johnson, Philip J., et al.
Publicado: (2022)

Using the aMAP Risk Score to Predict Late Recurrence Following Radiofrequency Ablation for Hepatocellular Carcinoma in Chinese Population: A Multicenter Study
por: Yang, Yi, et al.
Publicado: (2021)

aMAP is a validated pipeline for registration and segmentation of high-resolution mouse brain data
por: Niedworok, Christian J., et al.
Publicado: (2016)

Enhancing the usability and performance of structured association mapping algorithms using automation, parallelization, and visualization in the GenAMap software system
por: Curtis, Ross E, et al.
Publicado: (2012)

The aMAP Score is an Independent Risk Factor for Intermediate-stage Hepatocellular Carcinoma: A Large Retrospective Cohort Study
por: Chen, Yaying, et al.
Publicado: (2023)

Usefulness of aMAP Risk Score for Predicting Recurrence after Curative Treatment for Hepatocellular Carcinoma within Milan Criteria
por: Ohama, Hideko, et al.
Publicado: (2023)

AMAP assessment 2015: human health in the Arctic
por: Odland, Jon Øyvind, et al.
Publicado: (2016)

Oncological Effects and Prognostic Value of AMAP1 in Gastric Cancer
por: Li, Jiao, et al.
Publicado: (2021)

aMAP Score as a Predictor for Long-Term Outcomes in Patients with HBV-Related Acute-on-Chronic Liver Failure
por: Sun, Yunqing, et al.
Publicado: (2022)

Retrospective analysis of efficacy, safety, and prognostic factors in a cohort of Chinese hepatocellular carcinoma patients treated with drug-eluting bead transarterial chemoembolization
por: Chen, Sihan, et al.
Publicado: (2019)

GWAS in a Box: Statistical and Visual Analytics of Structured Associations via GenAMap
por: Xing, Eric P., et al.
Publicado: (2014)

Dual roles of AMAP1 in the transcriptional regulation and intracellular trafficking of carbonic anhydrase IX
por: Horikawa, Mei, et al.
Publicado: (2021)

The role of the Arctic Monitoring and Assessment Programme (AMAP) in reducing pollution of the Arctic and around the globe
por: Reiersen, Lars-Otto, et al.
Publicado: (2023)

GALAD outperforms aMAP and ALBI for predicting HCC in patients with compensated advanced chronic liver disease: A 12-year prospective study
por: Villa, Erica, et al.
Publicado: (2023)

AMAP1 as a negative-feedback regulator of nuclear factor-κB under inflammatory conditions
por: Tien, Dat Nguyen, et al.
Publicado: (2014)

The EGFR-GEP100-Arf6-AMAP1 Signaling Pathway Specific to Breast Cancer Invasion and Metastasis(†)
por: Sabe, Hisataka, et al.
Publicado: (2009)

Identifying cirrhosis, decompensated cirrhosis and hepatocellular carcinoma in health administrative data: A validation study
por: Lapointe-Shaw, Lauren, et al.
Publicado: (2018)

Co-Overexpression of GEP100 and AMAP1 Proteins Correlates with Rapid Local Recurrence after Breast Conservative Therapy
por: Kinoshita, Rumiko, et al.
Publicado: (2013)

Altered muscle activation patterns (AMAP): an analytical tool to compare muscle activity patterns of hemiparetic gait with a normative profile
por: Srivastava, Shraddha, et al.
Publicado: (2019)

High expression of AMAP1, an ARF6 effector, is associated with elevated levels of PD-L1 and fibrosis of pancreatic cancer
por: Tsutaho, Akio, et al.
Publicado: (2020)

Validation of an algorithm using inpatient electronic health records to determine the presence and severity of cirrhosis in patients with hepatocellular carcinoma in England: an observational study
por: Driver, Robert J, et al.
Publicado: (2019)

GEP100-Arf6-AMAP1-Cortactin Pathway Frequently Used in Cancer Invasion Is Activated by VEGFR2 to Promote Angiogenesis
por: Hashimoto, Ari, et al.
Publicado: (2011)

iAMAP-SCM: A Novel Computational Tool for Large-Scale Identification of Antimalarial Peptides Using Estimated Propensity Scores of Dipeptides
por: Charoenkwan, Phasit, et al.
Publicado: (2022)

Hepatocellular Carcinoma Screening Process Failures in Patients with Cirrhosis
por: Marquardt, Patrick, et al.
Publicado: (2021)

High level expression of AMAP1 protein correlates with poor prognosis and survival after surgery of head and neck squamous cell carcinoma patients
por: Sato, Hiroki, et al.
Publicado: (2014)

Validation of Malnutrition Screening Tools in Liver Cirrhosis
por: Traub, Julia, et al.
Publicado: (2020)

Development And Validation Of A Simple Model For Detection Of Early Hepatocellular Carcinoma In A Liver Cirrhosis Cohort
por: Li, Tao, et al.
Publicado: (2019)

Chinese guidelines on management of hepatic encephalopathy in cirrhosis
por: Xu, Xiao-Yuan, et al.
Publicado: (2019)

Bioinformatics-based screening of key genes for transformation of liver cirrhosis to hepatocellular carcinoma
por: Jiang, Chen Hao, et al.
Publicado: (2020)

Cell Differentiation Trajectory in Liver Cirrhosis Predicts Hepatocellular Carcinoma Prognosis and Reveals Potential Biomarkers for Progression of Liver Cirrhosis to Hepatocellular Carcinoma
por: He, Zhaobin, et al.
Publicado: (2022)

Rab5c promotes AMAP1–PRKD2 complex formation to enhance β1 integrin recycling in EGF-induced cancer invasion
por: Onodera, Yasuhito, et al.
Publicado: (2012)

Experimental Validation of Novel Glypican 3 Exosomes for the Detection of Hepatocellular Carcinoma in Liver Cirrhosis
por: Aydin, Yucel, et al.
Publicado: (2021)

Validation of Hepatocellular Carcinoma Risk Prediction Models in Patients with Hepatitis B-Related Cirrhosis
por: Cheng, Ran, et al.
Publicado: (2022)

Chinese guidelines on the management of liver cirrhosis (abbreviated version)
por: Xu, Xiao-Yuan, et al.
Publicado: (2020)

Validity of an Automated Algorithm to Identify Cirrhosis Using Electronic Health Records in Patients with Primary Biliary Cholangitis
por: Lu, Mei, et al.
Publicado: (2020)

ARF6 and AMAP1 are major targets of KRAS and TP53 mutations to promote invasion, PD-L1 dynamics, and immune evasion of pancreatic cancer
por: Hashimoto, Shigeru, et al.
Publicado: (2019)

Validity of an automated algorithm using diagnosis and procedure codes to identify decompensated cirrhosis using electronic health records
por: Lu, Mei, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_k1v10dupl7tt0q8o72ks6273f5